Lyovepraz 40mg powder for injection
Dexa Medica
Composition
Omeprazole | 40 mg |
Each Pack Contains
1 vial of 40 mg
Dosage Form
![]() | Powder for injection |
Dosage formPowder for injection
Flavor
None
W.H.O. Classification
A02B
Available In
![]() | Cambodia |
Warning

Alcohol
CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.

Machinery
CAUTIONThis item may not be safe for use while operating heavy machinery. Use with caution and after consultation with your doctor.

Pregnancy
CONSULT YOUR DOCTORSafety of this item for use during pregnancy has not been established. Please consult your doctor.

Lactation
NOT RECOMMENDEDThis item is not safe for use during lactation.
Indication
Alternative therapy for the following conditions which cannot be treated effectively with oral medication:
Duodenal ulcer
Gastric ulcer
Reflux Esophagitis
Zollinger-Ellison syndrome
Duodenal ulcer
Gastric ulcer
Reflux Esophagitis
Zollinger-Ellison syndrome
Dosage
UP TO 18 YEARS
There is no experience with omeprazole injection in children.
18 YEARS OLD AND ABOVE
1x1 40 mg, intravenously. Omeprazole intravenous should only be used where oral medication is inappropriate, e.g. in severely ill patients.
The dose used in the treatment of Zollinger-Ellison syndrome should be adjusted according to individual response.
Dilute with 10 ml WFI, do not used another solvent. Inject over a period of not less than 2.5 minutes. Inject at a rate no greater than 4 ml/minute.
ELDERLY PATIENTS
No dosage adjustment required.
PATIENTS WITH IMPAIRED HEPATIC FUNCTION
No dosage adjustment required. The normal dose of omeprazole 20 mg daily may be used in patients with severe hepatic disease.
PATIENTS WITH IMPAIRED RENAL FUNCTION
No dosage adjustment required.
There is no experience with omeprazole injection in children.
18 YEARS OLD AND ABOVE
1x1 40 mg, intravenously. Omeprazole intravenous should only be used where oral medication is inappropriate, e.g. in severely ill patients.
The dose used in the treatment of Zollinger-Ellison syndrome should be adjusted according to individual response.
Dilute with 10 ml WFI, do not used another solvent. Inject over a period of not less than 2.5 minutes. Inject at a rate no greater than 4 ml/minute.
ELDERLY PATIENTS
No dosage adjustment required.
PATIENTS WITH IMPAIRED HEPATIC FUNCTION
No dosage adjustment required. The normal dose of omeprazole 20 mg daily may be used in patients with severe hepatic disease.
PATIENTS WITH IMPAIRED RENAL FUNCTION
No dosage adjustment required.